FDA approves quick-acting drug to reverse painkiller ODs - KFVS12 News & Weather Cape Girardeau, Carbondale, Poplar Bluff

FDA approves quick-acting drug to reverse prescription painkiller ODs

Updated: April 3, 2014 02:31 PM
© Michael Matisse / Photodisc © Michael Matisse / Photodisc
  • SPONSORED BY SOUTHEAST HEALTHMore>>

  • New technology connects babies and families with webcams

    New technology connects babies and families with webcams

    New technology connects babies and families with webcams

    Thursday, July 31 2014 7:45 PM EDT2014-07-31 23:45:11 GMT
    The Heartland is now home to the newest cutting edge technology for moms and babies facing long hospitals stays when the little ones need special intensive care.
    The Heartland is now home to the newest cutting edge technology for moms and babies facing long hospitals stays when the little ones need special intensive care. 
  • Quinn signs epinephrine law for Illinois schools

    Quinn signs epinephrine law for Illinois schools

    Wednesday, July 30 2014 6:36 PM EDT2014-07-30 22:36:36 GMT
    A new bill signed into Illinois law says trained personnel at schools statewide will be able to administer injectable epinephrine for those appearing to have strong allergic reactions.
    A new bill signed into Illinois law says trained personnel at schools statewide will be able to administer injectable epinephrine for those appearing to have strong allergic reactions.
  • Illinois Medicaid restricts use of hepatitis drug

    Illinois Medicaid restricts use of hepatitis drug

    Wednesday, July 30 2014 2:41 PM EDT2014-07-30 18:41:49 GMT
    Illinois is placing tight restrictions on a new hepatitis C drug that costs $1,000 per pill. Medicaid patients must meet 25 criteria and get prior approval before the government health care program will pay for...
    Illinois is placing tight restrictions on a new hepatitis C drug that costs $1,000 per pill. Medicaid patients must meet 25 criteria and get prior approval before the government health care program will pay for Sovaldi.

THURSDAY, April 3, 2014 (HealthDay News) -- The first prescription treatment that can be used by family members or caregivers to treat an overdose of narcotic painkillers has been approved by the U.S. Food and Drug Administration.

Evzio is a hand-held auto injector that delivers a single dose of the drug naloxone into the muscle or beneath the skin. The injector can be carried in a pocket or stored in a medicine cabinet and is meant as an emergency treatment for people who have suffered a known or suspected overdose of powerful pain drugs called opioids.

Opioids include prescription narcotic painkillers such as Oxycontin, Vicodin and Percocet -- all of which have shown increasing rates of abuse in recent years.

"Tragically, the most recent data shows that more than 16,000 lives are lost each year due to opioid-related overdoses," FDA Commissioner Margaret Hamburg said in an agency statement. "In fact, drug overdose deaths, driven largely by prescription drug overdose deaths, are now the leading cause of injury death in the United States -- surpassing motor vehicle crashes."

She called Evzio's "fast-tracked" FDA approval "an important new tool in our arsenal to more effectively combat the devastating effects of opioid overdose."

Naloxone rapidly reverses the effects of overdose and is the standard treatment in such cases. However, current naloxone drugs have to be injected with a needle and their use is typically limited to trained medical personnel, the FDA noted.

"Evzio is the first combination drug-device product designed to deliver a dose of naloxone for administration outside of a health care setting," Dr. Bob Rappaport, director of the division of anesthesia, analgesia, and addiction products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

"Making this product available could save lives by facilitating earlier use of the drug in emergency situations," he explained.

When it's turned on, Evzio provides users with verbal instructions on how to deliver the medication. Family members and caregivers should learn all the instructions before they may have to use Evzio and should practice with the trainer device that comes with it, the FDA advised.

According to the FDA, one study involving 30 patients showed a shot of Evzio delivered the equivalent of a single dose of naloxone using a standard syringe. People who receive a shot of Evzio may experience "severe opioid withdrawal," the agency said.

There are dangers with quick withdrawal from "opioid depression," the FDA said, with symptoms such as nausea, vomiting, sweating and accelerated heart rate, and a risk for spikes in blood pressure, seizures and even cardiac arrest.

It also noted that repeat doses may be necessary and that Evzio is not a substitute for immediate medical care.

More information

The U.S. National Institute on Drug Abuse has more about opioids.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

310 Broadway
Cape Girardeau, MO 63701

FCC Public File
publicfile@kfvs12.com
573-335-1212
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KFVS12. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.